The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke.

BMC Neurol · 2014 · PMC4029902 · PMID 24886064

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Safety outcome (futility) If the trial shows no significant difference between the two treatment groups, the DSMC may stop the trial, if there also is a clear trend towards increased bleeding rate in one group.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.